FDA Drops Final Guidance On Safety Considerations For Neonatal Medical Products

The US FDA has published a final guidance document providing stakeholders with a framework for various safety evaluations they should consider when developing medical products for newborns, including devices. The guidance focuses on long-term evaluations of neurodevelopmental safety.

(Shutterstock)

More from Medtech Insight

More from Compliance